Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1.
Alonci
Andrea
A
Allegra
Alessandro
A
Bellomo
Giacomo
G
Quartarone
Eugenia
E
Oteri
Giacomo
G
Nastro
Enrico
E
Cicciù
Domenico
D
De Ponte
Francesco Saverio
FS
Musolino
Caterina
C
D000368:Aged; D000369:Aged, 80 and over; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy*; D010020:Osteonecrosis / Q000139:chemically induced*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000097:blood*